The internalization pathway and mechanism of uncoating of human rhinovirus serotype 2 (HRV2), a minor-group human rhinovirus, were investigated. Kinetic analysis revealed a late endosomal compartment as the site of capsid modification from D to C antigenicity. The conformational change as well as the infection was prevented by the specific V-ATPase inhibitor bafilomycin Al. A requirement for ATP was also demonstrated with purified endosomes in vitro. Capsid modifications occurred at a pH of 5.5 regardless of whether the virus was entrapped in isolated endosomes or free in solution. These findings suggest that the receptor is not directly involved in the structural modification of HRV2. Viral particles found in purified endosomes of infected cells were mostly devoid of RNA. This supports the hypothesis that uncoating of HRV2 occurs in intact endosomes rather than by a mechanism involving endosomal disruption with subsequent release of the RNA into the cytoplasm. (49, 51) has been shown to be a prerequisite for translocation into the cytoplasm (46, 54, 55) .
in the structural modification of HRV2. Viral particles found in purified endosomes of infected cells were mostly devoid of RNA. This supports the hypothesis that uncoating of HRV2 occurs in intact endosomes rather than by a mechanism involving endosomal disruption with subsequent release of the RNA into the cytoplasm.
Three steps determine the early events in viral infection of a host cell: adsorption to the plasma membrane by binding to specific receptors, penetration, and subsequent uncoating of the genome. It is well established that many enveloped and nonenveloped viruses enter a cell via receptor-mediated endocytosis, with membrane penetration and uncoating taking place from endosomes (23, 46) . Internalization of receptors and extracellular fluid is initiated by invagination of clathrin-coated and noncoated regions of the plasma membrane (21, 66) . After pinching off, these coated and noncoated preendosomal vesicles reach the same early endosome compartment (22) . In early endosomes, membrane proteins and the internalized material either are sorted into the recycling pathway or are directed via late endosomes to lysosomes for degradation (31) . Moreover, endocytic routes of various plasma membrane proteins, ligands, toxins, and viruses have even been shown to converge with elements of the biosynthetic apparatus (15, 29, 55) . Toxins and viruses are thereby transported to the respective compartment providing conditions suitable for delivery to the cytoplasm. The factors governing these different sorting mechanisms are largely unknown. At least, the low pH (6.5 to 5.0) prevailing in endocytic and exocytic compartments (49, 51) has been shown to be a prerequisite for translocation into the cytoplasm (46, 54, 55) .
Although the entry pathway of many enveloped viruses is well characterized (23, 46) , the early stages of infection of nonenveloped viruses remain obscure and controversial. In the case of picornaviruses, morphological as well as biochemical data have shown internalization of poliovirus to occur via coated pits and coated vesicles (45, 69, 71) . However, the site of uncoating has not been clearly defined. Using cell fractionation, Kronenberger et al. (33, 34) have localized intact poliovirus sedimenting at 160S and modified 135S particles in lipid vesicles, which could not be identified as bona fide endosomes. Thus, they proposed a mechanism whereby 135S particles, which have lost VP4 but still contain RNA, are transferred across cellular organelles and are subsequently uncoated to 80S empty capsids in the cytoplasm (34) . This is contradicted by the most recent results of Perez and Carrasco (56) , which favor uncoating in endosomes. Moreover, poliovirus degradation has not been detected up to 4 h after infection (7, 18, 68) , arguing against an internalization pathway with final transport to lysosomes. This is again in contrast to the results of other groups, who have found poliovirus particles associated with lysosomal fractions (33, 34) . Unlike poliovirus, human rhinovirus serotype 2 (HRV2), another member of the picornavirus family, seemed to be internalized by a clathrinindependent mechanism (45) . Kinetic analysis of HRV2 entry by Lonberg-Holm and Korant (39) suggested an ultimate transport to and degradation in lysosomes, providing indirect evidence for uncoating along the endosomal pathway. Yet, the occurrence of native virions and modified HRV in endocytic organelles has not been demonstrated.
The influence of low pH on the picornavirus infective pathway has also long been under debate. Earlier work on poliovirus was in favor of an acid-dependent step (43, 44, 71) , whereas recent results indicate that the low pH is not required for penetration and uncoating (18, 32, 56) . In addition, chloroquine, an agent used to elevate the pH in acidic intracellular compartments, has been shown by Gromeier and Wetz (18) to exert a stabilizing effect on the capsid in vitro, whereas Kronenberger et al. (32, 34) have demonstrated that it promotes the formation of 80S empty capsids in vivo. Data on HRVs support the notion that the low intravesicular pH is necessary for successful infection to occur. This has been demonstrated for both major (56) and minor (52) (26, 38, 40) .
Receptor binding can also result in conformational transitions of viral capsids. In vitro, poliovirus forms 135 and 80S particles upon incubation with extracts of susceptible cells or soluble forms of the poliovirus receptor at a neutral pH above 30°C (6, 20, 27, 50) . This again is in contradiction to in vivo data showing that intact poliovirus can be recovered from cells even 4 h after infection (7, 33, 69) . Furthermore, viable mutants resistant to the receptor-induced inactivation have been obtained (28) . The (52) . Because of the lack of sufficient quantities of isolated minor-group HRV receptors, i.e., the low-density lipoprotein receptor (LDLR) andC)2-macroglobulin receptor/LDLR-related protein, this virus-receptor interaction has not been studied so far in vitro (25) .
The question of where and how picornaviruses in general and human rhinoviruses in particular deliver their genome to the cytosol is therefore still open. By using HRV2, the internalization pathway of a minor receptor group HRV was reinvestigated in order to determine the intracellular site and the mechanism of uncoating. Our results indicate that successful infection of HeLa cells requires a low-pH-dependent, but receptor-independent, uncoating step of HRV2 in late endosomes. Immunoprecipitation of HRV2 from whole cells and endosomes. Immunocomplexes were formed by incubation of the antisera with lyophilized S. aureus cells in RIPA buffer as described elsewhere (52) . The cell pellets and supernatants were processed separately. Cell pellets were lysed in 150 ,ul of RIPA buffer (5) for 20 min at 0°C, and cell debris was removed by centrifugation. Alternatively, endosomal fractions were dissolved in Sx RIPA buffer. First, C-antigenic particles were precipitated with monoclonal antibody (MAb) 2G2 (52) . Second, native virus remaining in the supernatant of the first precipitation was recovered with a rabbit antiserum raised against HRV2. Both precipitates were washed once in RIPA buffer and then in PBS. Pellets were boiled in Laemmli sample buffer (35) and analyzed on SDS-12.5% polyacrylamide minigels. The gels were soaked in 1 M sodium salicylate for 30 min, dried, and exposed to X-ray film. Autoradiographs of dried gels were scanned by using an LKB Ultroscan XL densitometer, and the sum of the total peak areas of VP1, VP2, and VP3 precipitated with monoclonal and polyclonal antibodies was calculated.
MATERIALS AND METHODS

Chemicals
Preparation of endosome-enriched Golgi fractions. Cells were homogenized in 4 volumes of 0.25 M sucrose in TEA buffer (10 mM triethanolamine-10 mM acetic acid-I mM EDTA titrated with NaOH to pH 7.4) with a ball-bearing homogenizer (2) , and a postnuclear supernatant was prepared by centrifugation at 1,000 x g for 10 min. A gradient was formed by adjusting the postnuclear supernatant to 1.3 M sucrose in TEA buffer and overlaying it with 4 ml each of 1.1 and 0.25 M sucrose in TEA buffer (47) . After centrifugation in an SW40 rotor (Beckman Instruments) for 1 h at 40,000 rpm, an endosome-enriched Golgi fraction was collected at the 0. 25 (11, 47, 61) . Ninety-two fractions were collected (3 ml per fraction per h) and assayed for protein (4), radioactivity, and fluorescence.
Cell-free acidification assays. Acidification assays of FITCcontaining endosomes were carried out immediately after isolation, essentially as described previously (11, 12 single representative experiment are shown. All experiments were repeated three to five times with similar results.
RESULTS
In vitro acidification of HeLa cell endosome subcompartments. As a prerequisite for infection, HRV2 has to undergo a low-pH-dependent conformational change to C-antigenic particles (52); this takes place most likely in endosomes. Internalized ligands en route to lysosomes have been shown to gradually encounter a decreasingly lower pH in endosomal subcompartments, ranging from 6.5 to 5.0 (49, 60, 61, 70) . Since this is not a general property of all cell types (62) , the acidification of selectively labeled early and late endosomes was investigated in HeLa cells by an in vitro acidification assay (11, 13) . Early recycling endosomes (1, 61, 64) were labeled with FITC-transferrin. Late endosomes (60, 61) were labeled with the fluid-phase marker FITC-dextran either by a pulsechase (a 5-min pulse followed by a 10-min chase at 34°C) or under conditions known to block transport to lysosomes (continuous uptake for 2 h at 20°C) (17) . After homogenization, endosome-enriched Golgi fractions were prepared by flotation in discontinuous sucrose density gradients (11, 12, 47) . The respective endosome fractions were added to KCl-containing buffer, and the fluorescence was continuously recorded. A moderate drop in FITC fluorescence, indicative of intravesicular acidification, was seen for early endosomes after addition of ATP (Fig. 1A) . A more pronounced ATP-dependent acidification was evident for both preparations of FITC-dextranlabeled late endosomes (Fig. 1B and C) . In all cases, the K+/H+ ionophore nigericin completely dissipated the pH gradients. These experiments establish that, in HeLa cells, early and late endosomes indeed differ in their internal pH.
On the basis of pH calibration of the intravesicular dyes, the average pH in early endosomes was determined to be 6.9. For late endosomes a pH of 6.4 was found, regardless of whether the late endosomes were labeled by pulse-chase at 34°C or by incubation at 20°C (Fig. 1B and C (39) . Under these conditions a linear increase of total cell-associated HRV2 up to 25 min was observed ( Fig.  2A) . Following a lag period of about 10 min, maximum conversion (40% of total cell-associated virus) to C-antigenic particles was also obtained at 25 min. On the basis of the kinetics of transport through early endosomes (half-life, 3 to 5 min [60, 61] ), the conversion to C antigenicity is in accordance with arrival in late endosomes. Moreover, since the in vivo pH in early endosomes is clearly higher than 5.6, the threshold pH for conversion of isolated HRV2 (19) , this strongly suggests that the presence of the minor-group receptor does not significantly facilitate the conformational change of HRV2.
After 25 min a rapid decrease of cell-associated immunoprecipitable radioactivity was observed. This coincides with the arrival of ligands in lysosomes (31, 61) and is in accordance with the data of Lonberg-Holm and Korant (39) , who demonstrated trichloroacetic acid-soluble radioactivity after 20 min of infection. About half of the input virus is recovered from the supernatant in its C-antigenic form and represents eluted particles described by Lonberg-Holm and Korant (39) . Since the time course of conversion of cell-associated virus and that of the appearance of C-antigenic virus in the supernatant are identical, eluted particles are most likely due to recycling and not to release of surface-bound particles as originally assumed.
Colocalization of HRV2 with a fluid-phase marker in isolated endosomes. The results presented above as well as our previous investigations have provided indirect evidence for a conformational change of HRV2 in endocytic compartments (52) . To conditions plasma membranes, Golgi apparatus, endoplasmic reticulum, and endosomes are well resolved from high-density lysosomes (13, 47) . As shown in Fig. 3A, HRV2 colocalizes with FITC-dextran-labeled endosomes in the low-density region of the Percoll gradient well separated from the lysosomal marker enzyme 1-hexosaminidase. Since this gradient is ineffective at separating endosomes from other smooth membranes, the presence of HRV2 in endosomes was established by free-flow electrophoresis (11, 47, 61) , which separates particles on the basis of differences in surface charge. HRV2 and FITC-dextran were internalized as described above; microsomes were prepared and subjected to free-flow electrophoresis. Percoll density gradient. The lysosomal marker P-hex( the high-density region is well separated from FITC somes in the low-density region of the gradient. In as labeled vesicles colocalize with the fluid-phase marker (B) Microsomes were obtained by centrifugation of t] supernatant at 200,000 x g for 1 h. After mild tryl microsomes were subjected to free-flow electrophorn conditions described in Materials and Methods. FITC-d endosomes are shifted toward the anode, whereas the peak is more deflected to the cathode. A substantial fra labeled structures colocalize with FITC-dextran-con somes; the remainder migrates at a position charact recycling compartment (65). the major protein peak containing plasma memi plasmic reticulum, and Golgi apparatus is elutec whereas endosomes and lysosomes are shifted anode (11, 61) . Figure 3B demonstrates the coloc major fraction of HRV2 with FITC-dextran in tI deflected endosomes. However, virus particles ai at a position known to correspond to the recycl (Fig. 2A) ; it also demonstrates that uncoating is already completed after this period.
To strengthen the evidence for endosomal uncoating and/or penetration, cells were loaded with HRV2 at 20°C for 2 h, allowing for viral accumulation in late endosomes (see above). Under these conditions native virus is completely converted to C-antigenic particles (52) . Bafilomycin Al was then added, and after further incubation at 20°C the cells were shifted to 34°C to allow for protein synthesis. Under these conditions viral reproduction (Fig. SB, lane + 120) was indistinguishable from the control infection (lane C), whereas addition of bafilomycin prior to infection prevented viral reproduction (lane -30).
Analysis of viral particles in isolated endosomes. When native 150S virions are internalized, they are rapidly converted from D to C antigenicity (135S particles lacking VP4 and 80S particles which are also devoid of their genomic RNA [37, 39, 40, 42] ). The intracellular site where this process takes place has never been determined with certainty. Since our results were highly suggestive of penetration or even uncoating of HRV2 from endosomes, we analyzed the nature of subviral particles in these organelles. To exclude the attachment of lipophilic, conformationally altered virions to vesicles during the fractionation procedure, at first a control experiment in which isolated 150, 135, and 80S particles were added to a postnuclear supernatant of HeLa cells and subjected to flotation in sucrose density gradients was carried out. Under these conditions, mostly endosomes and Golgi elements float up to the 0.25-1.1 M sucrose interface (11, 47) ; no added viral particles were found associated with this fraction, excluding nonspecific attachment of viral particles (data not shown). Next, HRV2 was internalized for 10 min at 34°C, and an endosome-enriched fraction was prepared. Vesicles were disrupted with Nonidet P-40 and SDS, and viral particles were separated on linear sucrose density gradients (38) . As presented in Fig. 6A , about 10% native virions, 57% 135S particles, and 23% 80S particles were found in endosomes. However, in the presence of bafilomycin Al, exclusively native virus with a sedimentation constant of 150S could be detected (data not shown).
When virus internalization was carried out for 2 h at 20°C, a condition in which virus accumulates in late endosomes (Fig.  1C ) (17) , all cell-associated virus was converted to C-antigenic particles (52) . Examination of subviral particles recovered from endosomes under these conditions revealed 40% of 135S and 60% of 80S particles but no detectable native virions (Fig.  6B) . Again, bafilomycin Al completely inhibited the formation of C-antigenic particles (data not shown). These experiments demonstrate that HRV2 can efficiently uncoat and infect cells (Fig. SB) (52) when accumulated in late endosomes. In contrast to major-group rhinoviruses (36, 39) , the conformational change and uncoating of HRV2 can occur at 20°C. Taken together, our data strongly suggest that HRV2 is conformationally altered as well as uncoated in endosomes.
Establishment of an in vitro system: is the receptor required for conformational change and uncoating of HRV2? To investigate the requirements for a conformational change of HRV2 in isolated endosomes, 35S-labeled virus was internalized in the absence or presence of 70 mM NH4Cl (Fig. 4) . This lysosomotropic agent completely prevents the transition to C-antigenic particles; in contrast to bafilomycin Al, which irreversibly inhibits V-ATPases, it can be completely removed. To prevent passive acidification (see below) NH4Cl has to be present throughout the isolation procedure. After virus uptake, cells were homogenized and a postnuclear supernatant was subjected to separation on sucrose flotation gradients. About 60% of total HRV2 loaded onto the gradient could be recovered in an endosome-enriched Golgi fraction. No differences were found in recoveries and enrichment (about 80-fold with respect to the original homogenate) between control and NH4Cl- buffers (see Materials and Methods) the amount of C-antigenic particles and native virus was determined by immunoprecipitation with MAb 2G2 and then with polyclonal antiserum. Under control conditions (20-min internalization in the absence of NH4Cl), 78% of C-antigenic particles were immunoprecipitated from isolated endosomes. As already shown for total cell-associated virus (Fig. 4) , this conversion could be completely prevented by NH4C1 (Fig. 7A) . Therefore, all subsequent experiments were performed with virus internalized in the presence of NH4Cl, and the conformational change was then induced in vitro in isolated endosomes. Three methods of endosome acidification were employed.
(i) Artificial acidification. Isolated endosomes were incubated in highly permeable buffers of various pH values. To exclude passive acidification, the NH4Cl concentration was maintained at 70 mM (Fig. 7B) .
(ii) Passive acidification. Dilution of NH4Cl-loaded vesicles into NH4Cl-free medium results in a rapid efflux of membranepermeable NH3 due to the concentration gradient. The remaining intravesicular protons dissipate more slowly and therefore lead to a transient decrease in pH (8) (Fig. 7C) . [35S]methionine-labeled HRV2 was internalized into HeLa cells for 20 min at 34°C in the absence or presence of 70 mM NH4C1, endosomes were prepared, and the amount of C-antigenic particles was determined and quantitated as for Fig. 4 (A) . Prior to analysis the endosomes from ammonium chloride-treated cells were incubated with buffers of the indicated pH values (B). Endosomes as for panel B were incubated in acidification medium, pH 7.4 ( Fig. 1) , for 20 min at 34°C in the presence of the compounds indicated (C).
7C; also, Fig. 1 ). First we determined whether the minor group receptor can induce or facilitate the conformational transition to C-antigenic particles. It can be assumed that HRV2 is internalized together with its receptor into endosomes. Hence, this could result in a different pH dependence of structural conversion in the presence of the receptor within endosomes compared with isolated HRV2 (19) . Incubation of virus within endosomes in a pH 6.0 or 7.4 medium did not result in generation of C antigenicity (Fig. 7B) . However, maximal conformational change of 80% was observed by incubation of the endosome-entrapped virus in a pH 5.5 buffer. Thus the conformational change occurs at a pH of 5.5 regardless of whether the virus is trapped in endosomes or free in solution.
Therefore, within the resolution of the experiment, the presence of the receptor does not seem to modulate the pHdependent conformational change of HRV2.
As shown in Fig. 7C (Fig. 7C) . Taken together, these in vitro experiments show that the conformational change to C-antigenic particles can be induced in isolated endosomes by activation of the endosomal proton ATPase. This demonstrates that at least a subpopulation of endosomes can indeed lower its internal pH in vitro sufficiently to cause conversion to the C-antigenic form. This in vitro system now enables us to determine the requirements for uncoating of nonenveloped viruses from isolated endosomes.
DISCUSSION
The overall entry pathway of the minor-group rhinovirus HRV2 has been investigated in HeLa cells. After receptormediated endocytosis, incoming native virions are modified after a lag period of about 10 min to C-antigenic particles. This modification is induced by the low pH (<5.6) established by the vacuolar proton pump in late endosomes. The minor-group receptor seems to have primarily a binding function, rather than mediating the conversion to C antigenicity and/or uncoating. This situation seems to be similar to that of foot-andmouth disease virus, which can infect unsusceptible cells by utilizing the Fc receptor in the presence of virus-specific antibodies (48) .
Once the virions are in late endosomes, 135S particles are formed, and the RNA is released. Uncoating of the genome and membrane penetration presumably occur synchronously by extrusion of the RNA through a pore in the membrane, leaving 80S particles in the endosomal lumen. Residual native virus as well as modified particles are then transferred to lysosomes, where they are rapidly degraded. The significance of this pathway is supported by the data obtained with the specific inhibitor of the endosomal proton pump, bafilomycin Al. Modification of 150S native virus to C-antigenic 135 and 80S particles is completely blocked by this drug. Moreover, as a consequence thereof, viral infection is prevented.
Receptor-independent conversion and/or uncoating. The first step in virus infection of a host cell is the binding to a specific receptor. It is clearly established for poliovirus and major-group rhinoviruses that their respective receptors catalyze capsid modifications in vitro at physiological pH and temperature (16, 26, 27 (20, 36) . However, HRV2 was completely converted to C antigenicity when internalized at 20°C, with the majority of the particles being devoid of RNA. Moreover, infection occurred after the temperature was shifted to 34°C after addition of bafilomycin.
Taken together, these data are in accordance with receptorindependent conversion as well as uncoating of HRV2.
Compartment of conversion and uncoating. The specific V-ATPase inhibitor bafilomycin Al has proven very useful for unequivocal demonstration of low-pH dependence in the entry pathway of nonenveloped viruses. However, the exact intracellular site of picornavirus uncoating was still unclear, since various endocytic as well as exocytic organelles maintain a pH gradient to the surrounding cytoplasm (51). Therefore, a major aim of this study was to identify the compartment where the modification and uncoating of HRV2 takes place. For the first time, we demonstrate the presence of a picornavirus in highly purified isolated endosomes using free-flow electrophoresis.
Moreover, the kinetics of HRV2 degradation was in agreement with further transport to lysosomes. This differs from the data on poliovirus, for which no association with typical endosomal fractions was found (33, 34) and no degradation was observed (7, 18, 68) . As shown by inhibition studies with bafilomycin Al, the low pH established by the endosomal V-ATPase is the only determinant for HRV2 modification. On the basis of the kinetics of virus entry and conversion, this low-pH-induced conformational change occurs in late endosomes. Since HRV2 was able to infect cells when internalized at 20°C, a condition known to block transport between late endosomes and lysosomes, virus uncoating or penetration must take place from late endosomes.
Mechanism of membrane penetration and uncoating. Two mechanisms for membrane penetration and uncoating of nonenveloped viruses have been proposed.
(i) Membrane insertion of hydrophobic capsid proteins leads to destabilization of the endosomal membrane and subsequent disruption, thereby delivering modified virus particles to the cytosol. There, once penetrated, the modified virus is uncoated to empty capsids.
(ii) After the conformational transition, hydrophobic capsid protein(s) inserts into the endosomal membrane, eventually in concert with the respective receptor, and forms a pore or channel through which the viral genome is released into the cytosol and thereby uncoated.
In the case of poliovirus, Fricks and Hogle (10) have shown that the amino terminus of VPl which is externalized during the conformational change can form an amphipathic helix able to insert into the endosomal membrane. This again could lead to either membrane destabilization or pore formation. VPl of HRV2 seems to play a role in uncoating similar to that described for poliovirus: peptides derived from the N terminus of VPl induced release of internalized macromolecules from isolated endosomes (57, 58) . Recent mutational analysis has demonstrated that VP4 of poliovirus, the myristylated protein which is lost during the transition to 135S particles, could also play a role in the release of the RNA by insertion into the endosomal membrane (50) .
Virus penetration by an endosome-disrupting mechanism should result in the preferential loss of those virions which After binding to its receptor, HRV2 is internalized via clathrin-coated or noncoated pits and vesicles into early endosomes. There, the viral receptor is sorted via recycling endosomes back to the plasma membrane, whereas HRV2 is transferred to late endosomes. Once in late endosomes, HRV2 undergoes acid-induced conformational changes of its capsid proteins. This leads to insertion of viral proteins into the endosomal membrane, whereby a pore through which the RNA is released into the cytosol is formed. Conformationally altered RNA-containing and RNA-free particles are either recycled into the external medium or degraded in Iysosomes.
have undergone modification and membrane insertion and consequently induced endosome lysis. Therefore, few 135S particles and virtually no empty capsids should be present in isolated endosomes. We found 57% 135S and 23% 80S particles in isolated endosomes after 10 min of infection at 34°C and up to 40% 135S and 60% 80S particles after 2 h of internalization at 20°C. These data are in favor of a poreforming rather than an endosome-disrupting mechanism. Adenovirus, which penetrates via endosome disruption (9, 14) , is not degraded in lysosomes. In contrast, lysosomal degradation of HRV2 was clearly evident. Moreover, pore formation is also supported by our recent in vitro experiments, in which release of macromolecules of different molecular weights, cointernalized with HRV2 or adenovirus, was investigated. Virus-induced release of these markers was size independent for adenovirus but was dependent on the molecular weight for HRV2 (57, 58) . Therefore, we propose that HRV2 releases its RNA via a specific pore without disrupting the endosome. A similar mechanism has also been proposed by Perez and Carrasco (56) to describe the poliovirus-mediated, bafilomycin-inhibitable release of ox-sarcin into the cytoplasm. However, poliovirus uncoating per se is independent of low intravesicular pH.
Our data suggest the following concept for the early events of HRV2 infection (Fig. 8) . After binding and internalization into early endosomes, the virus-receptor complex is dissociated, probably as a result of the mildly acidic pH environment. While the receptor is recycled, HRV2 is transferred to late endosomes, where it is structurally modified by pH <5.6, established by the endosomal proton pump. Most likely, this results in membrane insertion of VP1, thereby allowing translocation of the viral RNA via a pore into the cytoplasm.
This raises the question of the mode of rhinovirus RNA translocation across the endosomal membrane and the driving forces underlying this process. Madshus et al. (45) provided very indirect evidence that the membrane potential might play a role in uncoating of HRV2, but not of poliovirus, since plasma membrane depolarization led to enhancement of infection for rhinovirus only. However, their experimental design did not allow differentiation of membrane potential effects on virus entry, conformational change, uncoating, or viral replication. In addition, the potential difference between endosomes and the cytoplasm is unknown. The plasma membrane maintains a transmembrane potential of about 40 mV, cell interior negative. Subcellular distribution of potential sensitive dyes in Dictyostelium amoebae suggests that acidic intracellular compartments are inside negative with respect to the cytoplasm (24) . This would pose a driving force of negatively charged molecules such as RNA out of the endosome. Using our in vitro system, we are currently testing an assay to measure RNA release from isolated endosomes to further investigate the mechanism and driving force of HRV2 uncoating.
